NCT05655351View on ClinicalTrials.gov

Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 21, 2022

Primary Completion Date

June 20, 2023

Study Completion Date

August 6, 2024

Conditions
CORONAVIRUS INFECTIONS
Interventions
BIOLOGICAL

anti-SARS-Cov-2 vaccination

For the purposes of the study, 10 mL of venous blood will be collected from each patient.

Trial Locations (1)

30029

CHU de Nîmes, Hôpital Universitaire Caremeau, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER